Article
Aptamer-enhanced immunotherapy targeting Non-Small Cell Lung Cancer cells: A conceptual approach towards T-cell mediated therapy
2026-01-06
Abstract excerpt
<title>Abstract</title> <p>Despite clinical advances with immune checkpoint inhibitors targeting the PD-1/PD-L1 axis, therapeutic response remains limited, as nearly 60% of PD-L1–positive patients fail to benefit from anti-PD-L1 monoclonal antibody therapy. Aptamers are short, single-stranded DNA or RNA oligonucleotides that selectively bind to target molecules with high affinity and specificity. Compared to mono...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 68c73e83-3ba8-5e78-9dc2-6b94541d5806
- DOI
- 10.21203/rs.3.rs-8243965/v1
